|Articles|July 8, 2020

California PrEP Push Reveals Underserved Demographics

The California PrEP Assistance Program, established to remove financial and structural barriers to PrEP access, had positive but uneven initial results.

Pre-Exposure Prophylaxis (PrEP) is effective at preventing sexual transmission of HIV, but access is limited for people with low income. The California PrEP Assistance Program (PrEP-AP), established to remove financial and structural barriers to PrEP access, had positive but uneven results. More information was shared at the International AIDS Society (IAS) AIDS 2020 Virtual Sessions.

PrEP-AP is intended to lower out-of-pocket costs for both uninsured and insured people who are eligible for PrEP services such as laboratory tests.The program also enables access to general sexually transmitted infection treatment and wellness.

PrEP-AP supplements PrEP medication access provided through manufacturer assistance programs in addition to covering the provision of post-exposure prophylaxis (PEP).

From April 2018-November 2019, active enrollment increased to more than 3,000 people. Among these people, 58% were uninsured, 38% had commercial insurance, and 4% had Medicare.

Under-enrolled populations included cisgender women, young people (age 18-24 years), black Americans, and people living in the Central Valley. Several targeted interventions have been introduced to address these deficits including state-funded PrEP navigation assistance.

To improve access in the Central Valley, PrEP-AP introduced a telemedicine option in September 2019. To address confidentiality concerns for young people and other groups, an additional benefit to allow PrEP-AP enrollment without using family or partner's health insurance is planned in the future. Further analysis can then guide further development.

“New enhancements have been introduced and can be evaluated to address these remaining barriers to PrEP,” study authors wrote.


Related to this article

FAQ: What You Need to Know About West Nile Virus in 2026
After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.